Pan-cancer analysis verifies COLGALT1 as a potential target for immunotherapy and survival prognosis

被引：0
|
作者：
Wang, Fengyan [1 ]
机构：
[1] Shandong First Med Univ & Shandong Prov Qianfosha, Affiliated Hosp 1, Jinan, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
COLGALT1; immune cell infiltration; immunotherapy; pancancer; tumor immune microenvironment;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
No.0161
引用
收藏
页码：49 / 49
页数：1
相关论文
共 50 条
  • [1] Pan-cancer analysis verifies COLGALT1 as a potential target for immunotherapy and survival prognosis
    Wang, Fengyan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 49 - 49
  • [2] Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
    Wang, Yuqi
    Yuan, Hongwei
    Yue, Genquan
    Zhao, Lingyan
    Xia, Yuan
    Zhang, Nan
    Li, Hailing
    Liu, Dongyang
    Su, Yubo
    Wang, Haisheng
    Gao, Yumin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
    Yuqi Wang
    Hongwei Yuan
    Genquan Yue
    Lingyan Zhao
    Yuan Xia
    Nan Zhang
    Hailing Li
    Dongyang Liu
    Yubo Su
    Haisheng Wang
    Yumin Gao
    Scientific Reports, 13
  • [4] Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy
    Chen, Fei
    Fan, Yumei
    Cao, Pengxiu
    Liu, Bing
    Hou, Jiajie
    Zhang, Bo
    Tan, Ke
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [5] YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
    Hu, Jian
    Qiu, Dongxu
    Yu, Anze
    Hu, Jiao
    Deng, Hao
    Li, Huihuang
    Yi, Zhenglin
    Chen, Jinbo
    Zu, Xiongbing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
    Liu, Yunqiang
    Tu, Mengjun
    Wang, Lingling
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 2171 - 2185
  • [7] An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
    Feng, Mingtao
    Cui, Huanhuan
    Tu, Wenjing
    Li, Liangdong
    Gao, Yang
    Chen, Lei
    Li, Deheng
    Chen, Xin
    Xu, Fengfeng
    Zhou, Changshuai
    Cao, Yiqun
    FRONTIERS IN GENETICS, 2022, 13
  • [8] Pan-cancer analysis identifies the IRF family as a biomarker for survival prognosis and immunotherapy
    Xu, Hua-Guo
    Chen, Can
    Chen, Lin-Yuan
    Pan, Shiyang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (03)
  • [9] Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
    Jia, Yuting
    Guo, Bin
    Zhang, Wenbin
    Wang, Feng
    Zhang, Yong
    Zhang, Quanmao
    Li, Erfeng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Pan-Cancer Analysis of the Oncogenic and Prognostic Role of PKM2: A Potential Target for Survival and Immunotherapy
    Liang, Nan
    Mi, Lusi
    Li, Jingting
    Li, Tong
    Chen, Jun
    Dionigi, Gianlorenzo
    Guan, Haixia
    Sun, Hui
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
12345